JoelBraunstein
MD
Location
St. Louis, MO, USA
Current Organization
C2N Diagnostics
News Featuring This Grantee
Research News
The PrecivityAD™ Alzheimer’s Test: A Q&A with C₂N’s Joel Braunstein, MD, MBA
Read this Q&A with Joel Braunstein, MD, MBA, president, CEO, and cofounder of C2N, describing how the PrecivityAD test is being used in clinical practice.
Research News
A Blood Sample Speeds Alzheimer’s Diagnosis
Alzheimer's Disease Research grantees tested just how well the PrecivityAD™ blood test is able to accurately detect amyloid plaques in the brain from a single blood draw.